Manufacturer
Pfizer NDC Codes
Finished products listed with the FDA under labeler names that contain “Pfizer”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vyndamaxtafamidis | Tafamidis 61 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-8730 |
| Vyndaqeltafamidis meglumine | Tafamidis meglumine 20 mg/1 | Capsule, Liquid filledOral | Pfizer Laboratories Div Pfizer Inc | 0069-1975 |
| Xalkoricrizotinib | Crizotinib 20 mg/1 | Capsule, Coated pelletsOral | Pfizer Laboratories Div Pfizer Inc | 0069-0251 |
| Xalkoricrizotinib | Crizotinib 50 mg/1 | Capsule, Coated pelletsOral | Pfizer Laboratories Div Pfizer Inc | 0069-0507 |
| Xalkoricrizotinib | Crizotinib 150 mg/1 | Capsule, Coated pelletsOral | Pfizer Laboratories Div Pfizer Inc | 0069-1500 |
| Xalkoricrizotinib | Crizotinib 250 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-8140 |
| Xalkoricrizotinib | Crizotinib 200 mg/1 | CapsuleOral | Pfizer Laboratories Div Pfizer Inc | 0069-8141 |
| Xeljanztofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-1001 |
| Xeljanztofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-1002 |
| Xeljanztofacitinib | Tofacitinib citrate 1 mg/mL | SolutionOral | Pfizer Laboratories Div Pfizer Inc | 0069-1029 |
| Xeljanz XRtofacitinib | Tofacitinib citrate 11 mg/1 | Tablet, Film coated, Extended releaseOral | Pfizer Laboratories Div Pfizer Inc | 0069-0501 |
| Xeljanz XRtofacitinib | Tofacitinib citrate 22 mg/1 | Tablet, Film coated, Extended releaseOral | Pfizer Laboratories Div Pfizer Inc | 0069-0502 |
| Zarontinethosuximide | Ethosuximide 250 mg/1 | CapsuleOral | Parke-Davis Div of Pfizer Inc | 0071-0237 |
| Zarontinethosuximide | Ethosuximide 250 mg/5mL | SolutionOral | Parke-Davis Div of Pfizer Inc | 0071-2418 |
| Zavzpretzavegepant | Zavegepant hydrochloride 10 mg/.1mL | SprayNasal | Pfizer Laboratories Div Pfizer Inc | 0069-3500 |
| Zirabevbevacizumab-bvzr | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0315 |
| Zirabevbevacizumab-bvzr | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0342 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 500 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0400 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 250 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-3060 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 500 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-3070 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | Pfizer Laboratories Div Pfizer Inc | 0069-3120 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | Pfizer Laboratories Div Pfizer Inc | 0069-3130 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | Pfizer Laboratories Div Pfizer Inc | 0069-3140 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 500 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-3150 |
| Zithromaxazithromycin dihydrate | Azithromycin dihydrate 250 mg/1 | Tablet, Film coatedOral | Pfizer Laboratories Div Pfizer Inc | 0069-4061 |